Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats

The profile of sphingomyelin and its metabolites shows changes in the plasma, organs, and tissues of patients with cardiovascular, renal, and metabolic diseases. The objective of this study was to investigate the effect of empagliflozin on the levels of sphingomyelin and its metabolites, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Villavicencio, Roxana, Flores-Estrada, Javier, Franco, Martha, Escalante, Bruno, Pérez-Méndez, Oscar, Mercado, Adriana, Bautista-Pérez, Rocio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910883/
https://www.ncbi.nlm.nih.gov/pubmed/35270028
http://dx.doi.org/10.3390/ijms23052883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910883/
https://www.ncbi.nlm.nih.gov/pubmed/35270028
http://dx.doi.org/10.3390/ijms23052883

Ejemplares similares